LEVIN ARTHUR A 4
4 · Avidity Biosciences, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
LEVIN ARTHUR A
Director
Transactions
- Exercise/Conversion
Common Stock
2025-08-06$22.34/sh+107,500$2,401,550→ 127,150 total - Sale
Common Stock
2025-08-06$47.62/sh−107,500$5,118,881→ 19,650 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-06−107,500→ 12,500 totalExercise: $22.34Exp: 2031-02-01→ Common Stock (107,500 underlying)
Holdings
- 131,372(indirect: By Trust)
Common Stock
- 22,500(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on October 17, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $47.50 to $48.02. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option is fully vested and exercisable as of the date of this Report.